Anne Moscona - Publications

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Microbiology Biology

110 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Marcink TC, Zipursky G, Cheng W, Stearns K, Stenglein S, Golub K, Cohen F, Bovier F, Pfalmer D, Greninger AL, Porotto M, des Georges A, Moscona A. Subnanometer structure of an enveloped virus fusion complex on viral surface reveals new entry mechanisms. Science Advances. 9: eade2727. PMID 36763666 DOI: 10.1126/sciadv.ade2727  0.445
2022 Reynard O, Gonzalez C, Dumont C, Iampietro M, Ferren M, Le Guellec S, Laurie L, Mathieu C, Carpentier G, Roseau G, Bovier FT, Zhu Y, Le Pennec D, Montharu J, Addetia A, ... ... Moscona A, et al. Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection. Nature Communications. 13: 6439. PMID 36307480 DOI: 10.1038/s41467-022-33832-6  0.31
2022 Schmitz KS, Geers D, de Vries RD, Bovier TF, Mykytyn AZ, Geurts van Kessel CH, Haagmans BL, Porotto M, de Swart RL, Moscona A. Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern. Mbio. 13: e0124922. PMID 35695453 DOI: 10.1128/mbio.01249-22  0.341
2022 Reynard O, Gonzalez C, Dumont C, Iampietro M, Ferren M, Guellec SL, Lajoie L, Mathieu C, Carpentier G, Roseau G, Bovier F, Zhu Y, Pennec DL, Montharu J, Addetia A, ... ... Moscona A, et al. Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection. Research Square. PMID 35677066 DOI: 10.21203/rs.3.rs-1700877/v1  0.311
2021 Kreft IC, Winiarczyk RRA, Tanis FJ, van der Zwaan C, Schmitz KS, Hoogendijk AJ, de Swart RL, Moscona A, Porotto M, Salvatori DCF, de Vries RD, de Maat MPM, van den Biggelaar M, van Vlijmen BJM. Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model. Thrombosis Research. 210: 6-11. PMID 34954402 DOI: 10.1016/j.thromres.2021.12.015  0.324
2021 Marcink TC, Porotto M, Moscona A. Parainfluenza virus entry at the onset of infection. Advances in Virus Research. 111: 1-29. PMID 34663496 DOI: 10.1016/bs.aivir.2021.07.001  0.434
2021 Greninger AL, Rybkina K, Lin MJ, Drew-Bear J, Marcink TC, Shean RC, Makhsous N, Boeckh M, Harder O, Bovier F, Burstein SR, Niewiesk S, Rima BK, Porotto M, Moscona A. Human parainfluenza virus evolution during lung infection of immunocompromised humans promotes viral persistence. The Journal of Clinical Investigation. PMID 34609969 DOI: 10.1172/JCI150506  0.417
2021 Ferren M, Favède V, Decimo D, Iampietro M, Lieberman NAP, Weickert JL, Pelissier R, Mazelier M, Terrier O, Moscona A, Porotto M, Greninger AL, Messaddeq N, Horvat B, Mathieu C. Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection. Nature Communications. 12: 5809. PMID 34608167 DOI: 10.1038/s41467-021-26096-z  0.307
2021 Stelitano D, Weisberg SP, Goldklang MP, Zhu Y, Bovier FT, Kalantarov GF, Greco G, Decimo D, Franci G, Cennamo M, Portella G, Galdiero M, Mathieu C, Horvat B, Trakht IN, ... Moscona A, et al. Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals. Msphere. e0057121. PMID 34319126 DOI: 10.1128/mSphere.00571-21  0.352
2021 Bovier FT, Rybkina K, Biswas S, Harder O, Marcink TC, Niewiesk S, Moscona A, Alabi CA, Porotto M. Inhibition of Measles Viral Fusion Is Enhanced by Targeting Multiple Domains of the Fusion Protein. Acs Nano. PMID 34291895 DOI: 10.1021/acsnano.1c02057  0.312
2021 Mathieu C, Bovier FT, Ferren M, Lieberman NAP, Predella C, Lalande A, Peddu V, Lin MJ, Addetia A, Patel A, Outlaw V, Corneo B, Dorrello NV, Briese T, Hardie D, ... ... Moscona A, et al. Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain. Mbio. e0079921. PMID 34061592 DOI: 10.1128/mBio.00799-21  0.391
2021 Outlaw VK, Cheloha RW, Jurgens EM, Bovier FT, Zhu Y, Kreitler DF, Harder O, Niewiesk S, Porotto M, Gellman SH, Moscona A. Engineering Protease-Resistant Peptides to Inhibit Human Parainfluenza Viral Respiratory Infection. Journal of the American Chemical Society. PMID 33825470 DOI: 10.1021/jacs.1c01565  0.396
2021 de Vries RD, Schmitz KS, Bovier FT, Predella C, Khao J, Noack D, Haagmans BL, Herfst S, Stearns KN, Drew-Bear J, Biswas S, Rockx B, McGill G, Dorrello NV, Gellman SH, ... ... Moscona A, et al. Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science (New York, N.Y.). PMID 33597220 DOI: 10.1126/science.abf4896  0.312
2020 de Vries RD, Schmitz KS, Bovier FT, Noack D, Haagmans BL, Biswas S, Rockx B, Gellman SH, Alabi CA, de Swart RL, Moscona A, Porotto M. Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets. Biorxiv : the Preprint Server For Biology. PMID 33173865 DOI: 10.1101/2020.11.04.361154  0.314
2020 Outlaw VK, Bovier FT, Mears MC, Cajimat MN, Zhu Y, Lin MJ, Addetia A, Lieberman NAP, Peddu V, Xie X, Shi PY, Greninger AL, Gellman SH, Bente DA, Moscona A, et al. Inhibition of Coronavirus Entry and by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain. Mbio. 11. PMID 33082259 DOI: 10.1128/mBio.01935-20  0.348
2020 Marcink TC, Wang T, des Georges A, Porotto M, Moscona A. Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces. Plos Pathogens. 16: e1008883. PMID 32956394 DOI: 10.1371/Journal.Ppat.1008883  0.58
2020 Lieberman NAP, Peddu V, Xie H, Shrestha L, Huang ML, Mears MC, Cajimat MN, Bente DA, Shi PY, Bovier F, Roychoudhury P, Jerome KR, Moscona A, Porotto M, Greninger AL. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. Plos Biology. 18: e3000849. PMID 32898168 DOI: 10.1371/Journal.Pbio.3000849  0.374
2020 Outlaw VK, Kreitler DF, Stelitano D, Porotto M, Moscona A, Gellman SH. Effects of single α-to-β residue replacements on recognition of an extended segment in a viral fusion protein. Acs Infectious Diseases. PMID 32692914 DOI: 10.1021/Acsinfecdis.0C00385  0.33
2020 Marcink TC, Yariv E, Rybkina K, Más V, Bovier FT, des Georges A, Greninger AL, Alabi CA, Porotto M, Ben-Tal N, Moscona A. Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy. Mbio. 11. PMID 32047132 DOI: 10.1128/Mbio.03203-19  0.577
2020 Moscona A. Chikungunya infection: de-linking replication from symptomatology reveals the central role of muscle. The Journal of Clinical Investigation. 130: 1099-1101. PMID 32039916 DOI: 10.1172/Jci134746  0.37
2020 Outlaw VK, Lemke JT, Zhu Y, Gellman SH, Porotto M, Moscona A. Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor. Journal of the American Chemical Society. PMID 31951396 DOI: 10.2210/Pdb6O40/Pdb  0.475
2019 Mendonça DA, Figueira TN, Melo MN, Harder O, Niewiesk S, Moscona A, Porotto M, Veiga AS. Self-assembly Stability Compromises the Efficacy of Tryptophan-Containing Designed Anti-measles Virus Peptides. Journal of Nanomedicine & Nanotechnology. 10. PMID 31572621 DOI: 10.35248/2157-7439.19.10.528  0.326
2019 Outlaw VK, Bottom-Tanzer S, Kreitler DF, Gellman SH, Porotto M, Moscona A. Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent. Journal of the American Chemical Society. PMID 31268705 DOI: 10.2210/Pdb6Nyx/Pdb  0.499
2019 Porotto M, Ferren M, Chen YW, Siu Y, Makhsous N, Rima B, Briese T, Greninger AL, Snoeck HW, Moscona A. Authentic Modeling of Human Respiratory Virus Infection in Human Pluripotent Stem Cell-Derived Lung Organoids. Mbio. 10. PMID 31064833 DOI: 10.1128/Mbio.00723-19  0.418
2019 Bottom-Tanzer SF, Rybkina K, Bell JN, Alabi CA, Mathieu C, Lu M, Biswas S, Vasquez M, Porotto M, Melero JA, Más V, Moscona A. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism. Mbio. 10. PMID 30782664 DOI: 10.1128/Mbio.02900-18  0.541
2019 Mathieu C, Ferren M, Jurgens E, Dumont C, Rybkina K, Harder O, Stelitano D, Madeddu S, Sanna G, Schwartz D, Biswas S, Hardie D, Hashiguchi T, Moscona A, Horvat B, et al. Measles virus bearing MIBE-derived fusion protein is pathogenic after infection via the respiratory route. Journal of Virology. PMID 30728259 DOI: 10.1128/Jvi.01862-18  0.498
2018 Angius F, Smuts H, Rybkina K, Stelitano D, Eley B, Wilmshurst J, Ferren M, Lalande A, Mathieu C, Moscona A, Horvat B, Hashiguchi T, Porotto M, Hardie D. Analysis of a subacute sclerosing panencephalitis (SSPE) Genotype B3 virus from the 2009/10 South African measles epidemic shows hyperfusogenic F proteins contribute to measles virus infection in the brain. Journal of Virology. PMID 30487282 DOI: 10.1128/Jvi.01700-18  0.504
2018 Figueira TN, Mendonça DA, Gaspar D, Melo MN, Moscona A, Porotto M, Castanho MARB, Veiga AS. Structure-Stability-Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles. Acs Nano. PMID 30230818 DOI: 10.1021/Acsnano.8B01422  0.391
2018 Figueira TN, Augusto MT, Rybkina K, Stelitano D, Noval MG, Harder OE, Veiga AS, Huey D, Alabi CA, Biswas S, Niewiesk S, Moscona A, Santos NC, Castanho MARB, Porotto M. Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to plasma membrane. Bioconjugate Chemistry. PMID 30169965 DOI: 10.1021/Acs.Bioconjchem.8B00527  0.5
2018 Iketani S, Shean RC, Ferren M, Makhsous N, Aquino DB, des Georges A, Rima B, Mathieu C, Porotto M, Moscona A, Greninger AL. Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation. Mbio. 9. PMID 29970463 DOI: 10.1128/Mbio.00898-18  0.518
2018 Mathieu C, Porotto M, Figueira T, Horvat B, Moscona A. Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates. The Journal of Infectious Diseases. PMID 29566184 DOI: 10.1093/Infdis/Jiy152  0.416
2017 Augusto MT, Hollmann A, Porotto M, Moscona A, Santos NC. Antiviral Lipopeptide-Cell Membrane Interaction Is Influenced by PEG Linker Length. Molecules (Basel, Switzerland). 22. PMID 28714870 DOI: 10.3390/Molecules22071190  0.361
2017 Figueira TN, Freire JM, Cunha-Santos C, Heras M, Gonçalves J, Moscona A, Porotto M, Salomé Veiga A, Castanho MA. Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance. Scientific Reports. 7: 45647. PMID 28358389 DOI: 10.1038/Srep45647  0.318
2017 Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A. Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides. Scientific Reports. 7: 43610. PMID 28344321 DOI: 10.1038/Srep43610  0.473
2016 Figueira TN, Palermo LM, Veiga AS, Huey D, Alabi CA, Santos NC, Welsch JC, Mathieu C, Horvat B, Niewiesk S, Moscona A, Castanho MARB, Porotto M. In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence. Journal of Virology. 91. PMID 27733647 DOI: 10.1128/Jvi.01554-16  0.442
2016 Palermo LM, Uppal M, Skrabanek L, Zumbo P, Germer S, Toussaint NC, Rima BK, Huey D, Niewiesk S, Porotto M, Moscona A. Features of Circulating Parainfluenza Virus Required for Growth in Human Airway. Mbio. 7. PMID 26980833 DOI: 10.1128/Mbio.00235-16  0.511
2016 Gui L, Jurgens E, Ebner JL, Porotto M, Moscona A, Lee KK. Erratum for Gui et al., Electron Tomography Imaging of Surface Glycoproteins on Human Parainfluenza Virus 3: Association of Receptor Binding and Fusion Proteins before Receptor Engagement. Mbio. 7. PMID 26787830 DOI: 10.1128/Mbio.01928-15  0.38
2015 Gui L, Jurgens EM, Ebner JL, Porotto M, Moscona A, Lee KK. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement. Mbio. 6: e02393-14. PMID 25691596 DOI: 10.1128/Mbio.02393-14  0.561
2015 Jurgens EM, Mathieu C, Palermo LM, Hardie D, Horvat B, Moscona A, Porotto M. Measles fusion machinery is dysregulated in neuropathogenic variants. Mbio. 6. PMID 25670774 DOI: 10.1128/Mbio.02528-14  0.519
2015 Palgen JL, Jurgens EM, Moscona A, Porotto M, Palermo LM. Unity in diversity: shared mechanism of entry among paramyxoviruses. Progress in Molecular Biology and Translational Science. 129: 1-32. PMID 25595799 DOI: 10.1016/Bs.Pmbts.2014.10.001  0.558
2015 Mathieu C, Huey D, Jurgens E, Welsch JC, DeVito I, Talekar A, Horvat B, Niewiesk S, Moscona A, Porotto M. Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides. Journal of Virology. 89: 1143-55. PMID 25378493 DOI: 10.1128/Jvi.02417-14  0.446
2015 Gui L, Jurgens EM, Ebner JL, Porotto M, Moscona A, Lee KK. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: Association of receptor binding and fusion proteins before receptor engagement Mbio. 6. DOI: 10.1128/mBio.02393-14  0.351
2014 Palmer SG, DeVito I, Jenkins SG, Niewiesk S, Porotto M, Moscona A. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection. Journal of Virology. 88: 13495-502. PMID 25210187 DOI: 10.1128/Jvi.01965-14  0.546
2014 Palmer SG, DeVito I, Jenkins SG, Niewiesk S, Porotto M, Moscona A. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection Journal of Virology. 88: 13495-13502. DOI: 10.1128/JVI.01965-14  0.337
2014 Englund JA, Moscona A. Paramyxoviruses: Parainfluenza Viruses Viral Infections of Humans: Epidemiology and Control. 579-600. DOI: 10.1007/978-1-4899-7448-8_25  0.4
2013 Xu R, Palmer SG, Porotto M, Palermo LM, Niewiesk S, Wilson IA, Moscona A. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo. Mbio. 4: e00803-13. PMID 24149514 DOI: 10.1128/Mbio.00803-13  0.586
2013 Welsch JC, Talekar A, Mathieu C, Pessi A, Moscona A, Horvat B, Porotto M. Fatal measles virus infection prevented by brain-penetrant fusion inhibitors Journal of Virology. 87: 13785-13794. PMID 24109233 DOI: 10.1128/Jvi.02436-13  0.424
2013 Talekar A, Moscona A, Porotto M. Measles virus fusion machinery activated by sialic acid binding globular domain Journal of Virology. 87: 13619-13627. PMID 24109225 DOI: 10.1128/Jvi.02256-13  0.547
2013 Talekar A, DeVito I, Salah Z, Palmer SG, Chattopadhyay A, Rose JK, Xu R, Wilson IA, Moscona A, Porotto M. Identification of a region in the stalk domain of the nipah virus receptor binding protein that is critical for fusion activation. Journal of Virology. 87: 10980-96. PMID 23903846 DOI: 10.1128/Jvi.01646-13  0.543
2012 Porotto M, Salah ZW, Gui L, DeVito I, Jurgens EM, Lu H, Yokoyama CC, Palermo LM, Lee KK, Moscona A. Regulation of paramyxovirus fusion activation, the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state Journal of Virology. 86: 12838-12848. PMID 22993149 DOI: 10.1128/Jvi.01965-12  0.536
2012 Palmer SG, Porotto M, Palermo LM, Cunha LF, Greengard O, Moscona A. Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue Mbio. 3. PMID 22669629 DOI: 10.1128/Mbio.00137-12  0.569
2012 Pessi A, Langella A, Capitò E, Ghezzi S, Vicenzi E, Poli G, Ketas T, Mathieu C, Cortese R, Horvat B, Moscona A, Porotto M. A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity Plos One. 7. PMID 22666328 DOI: 10.1371/Journal.Pone.0036833  0.476
2012 Porotto M, Salah Z, DeVito I, Talekar A, Palmer SG, Xu R, Wilson IA, Moscona A. The second receptor binding site of the globular head of the newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion Journal of Virology. 86: 5730-5741. PMID 22438532 DOI: 10.1128/Jvi.06793-11  0.529
2012 Talekar A, Pessi A, Glickman F, Sengupta U, Briese T, Whitt MA, Mathieu C, Horvat B, Moscona A, Porotto M. Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment Plos One. 7. PMID 22396728 DOI: 10.1371/Journal.Pone.0030538  0.427
2012 Porotto M, Palmer SG, Palermo LM, Moscona A. Mechanism of fusion triggering by human parainfluenza virus type III: Communication between viral glycoproteins during entry Journal of Biological Chemistry. 287: 778-793. PMID 22110138 DOI: 10.1074/Jbc.M111.298059  0.576
2011 Lee KK, Pessi A, Gui L, Santoprete A, Talekar A, Moscona A, Porotto M. Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus Journal of Biological Chemistry. 286: 42141-42149. PMID 21994935 DOI: 10.1074/Jbc.M111.254243  0.455
2011 Porotto M, Devito I, Palmer SG, Jurgens EM, Yee JL, Yokoyama CC, Pessi A, Moscona A. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. Journal of Virology. 85: 12867-80. PMID 21976650 DOI: 10.1128/Jvi.05873-11  0.51
2011 Farzan SF, Palermo LM, Yokoyama CC, Orefice G, Fornabaio M, Sarkar A, Kellogg GE, Greengard O, Porotto M, Moscona A. Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery Journal of Biological Chemistry. 286: 37945-37954. PMID 21799008 DOI: 10.1074/Jbc.M111.256248  0.56
2011 Porotto M, Yi F, Moscona A, LaVan DA. Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus. Plos One. 6: e16874. PMID 21390296 DOI: 10.1371/Journal.Pone.0016874  0.499
2010 Porotto M, Rockx B, Yokoyama CC, Talekar A, DeVito I, Palermo LM, Liu J, Cortese R, Lu M, Feldmann H, Pessi A, Moscona A. Inhibition of Nipah Virus Infection In Vivo: Targeting an early stage of paramyxovirus fusion activation during viral entry Plos Pathogens. 6. PMID 21060819 DOI: 10.1371/Journal.Ppat.1001168  0.449
2010 Moscona A, Porotto M, Palmer S, Tai C, Aschenbrenner L, Triana-Baltzer G, Li QX, Wurtman D, Niewiesk S, Fang F. A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo Journal of Infectious Diseases. 202: 234-241. PMID 20533871 DOI: 10.1086/653621  0.49
2010 Porotto M, Yokoyama CC, Palermo LM, Mungall B, Aljofan M, Cortese R, Pessi A, Moscona A. Viral entry inhibitors targeted to the membrane site of action Journal of Virology. 84: 6760-6768. PMID 20357085 DOI: 10.1128/Jvi.00135-10  0.501
2010 Wolf MC, Freiberg AN, Zhang T, Akyol-Ataman Z, Grock A, Hong PW, Li J, Watson NF, Fang AQ, Aguilar HC, Porotto M, Honko AN, Damoiseaux R, Miller JP, Woodson SE, ... ... Moscona A, et al. A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences of the United States of America. 107: 3157-62. PMID 20133606 DOI: 10.1073/Pnas.0909587107  0.539
2010 Peluso RW, Moscona A. Respiroviruses: Parainfluenza Virus Topley and Wilson's Microbiology and Microbial Infections. DOI: 10.1002/9780470688618.Taw0242  0.518
2009 Aljofan M, Sganga ML, Lo MK, Rootes CL, Porotto M, Meyer AG, Saubern S, Moscona A, Mungall BA. Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro Virology Journal. 6. PMID 19889218 DOI: 10.1186/1743-422X-6-187  0.413
2009 Palermo LM, Porotto M, Yokoyama CC, Palmer SG, Mungall BA, Greengard O, Niewiesk S, Moscona A. Human parainfluenza virus infection of the airway epithelium: Viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity Journal of Virology. 83: 6900-6908. PMID 19386708 DOI: 10.1128/Jvi.00475-09  0.595
2009 Porotto M, Yokoyama CC, Orefice G, Kim HS, Aljofan M, Mungall BA, Moscona A. Kinetic dependence of paramyxovirus entry inhibition Journal of Virology. 83: 6947-6951. PMID 19369345 DOI: 10.1128/Jvi.00416-09  0.404
2009 Porotto M, Orefice G, Yokoyama CC, Mungall BA, Realubit R, Sganga ML, Aljofan M, Whitt M, Glickman F, Moscona A. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy Journal of Virology. 83: 5148-5155. PMID 19264786 DOI: 10.1128/Jvi.00164-09  0.412
2009 Moscona A. Global transmission of oseltamivir-resistant influenza. The New England Journal of Medicine. 360: 953-6. PMID 19258250 DOI: 10.1056/Nejmp0900648  0.455
2008 Aljofan M, Porotto M, Moscona A, Mungall BA. Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus Journal of Virological Methods. 149: 12-19. PMID 18313148 DOI: 10.1016/J.Jviromet.2008.01.016  0.403
2008 Moscona A. Medical management of influenza infection Annual Review of Medicine. 59: 397-413. PMID 17939760 DOI: 10.1146/Annurev.Med.59.061506.213121  0.449
2007 Moscona A. CSI microbiology: Emerging pathogens and a staged strategy for detection and discovery Journal of Infectious Diseases. 196: 1727-1728. PMID 18190250 DOI: 10.1086/524313  0.368
2007 Porotto M, Carta P, Deng Y, Kellogg GE, Whitt M, Lu M, Mungall BA, Moscona A. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors Journal of Virology. 81: 10567-10574. PMID 17652384 DOI: 10.1128/Jvi.01181-07  0.452
2007 Palermo LM, Porotto M, Greengard O, Moscona A. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II Journal of Virology. 81: 9152-9161. PMID 17567695 DOI: 10.1128/Jvi.00888-07  0.566
2007 Moscona A, McKimm-Breschkin J. News about influenza B drug resistance that cannot be ignored Journal of the American Medical Association. 297: 1492-1493. PMID 17405975 DOI: 10.1001/Jama.297.13.1492  0.421
2007 Porotto M, Fornabaio M, Kellogg GE, Moscona A. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism Journal of Virology. 81: 3216-3228. PMID 17229690 DOI: 10.1128/Jvi.02617-06  0.506
2006 Loughlin GM, Moscona A. The cell biology of acute childhood respiratory disease: therapeutic implications. Pediatric Clinics of North America. 53: 929-59, ix-x. PMID 17027618 DOI: 10.1016/J.Pcl.2006.08.004  0.429
2006 Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A. Inhibition of Hendra virus fusion Journal of Virology. 80: 9837-9849. PMID 16973588 DOI: 10.1128/Jvi.00736-06  0.478
2006 Porotto M, Fornabaio M, Greengard O, Murrell MT, Kellogg GE, Moscona A. Paramyxovirus receptor-binding molecules: Engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site Journal of Virology. 80: 1204-1213. PMID 16414997 DOI: 10.1128/Jvi.80.3.1204-1213.2006  0.686
2005 Moscona A. Oseltamivir resistance - Disabling our influenza defenses New England Journal of Medicine. 353: 2633-2636. PMID 16371626 DOI: 10.1056/Nejmp058291  0.46
2005 Moscona A. Neuraminidase inhibitors for influenza New England Journal of Medicine. 353: 1363-1373. PMID 16192481 DOI: 10.1056/Nejmra050740  0.482
2005 Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease Journal of Clinical Investigation. 115: 1688-1698. PMID 16007245 DOI: 10.1172/Jci25669  0.552
2005 Porotto M, Murrell M, Greengard O, Doctor L, Moscona A. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein Journal of Virology. 79: 2383-2392. PMID 15681439 DOI: 10.1128/Jvi.79.4.2383-2392.2005  0.733
2004 Porotto M, Murrell M, Greengard O, Lawrence MC, McKimm-Breschkin JL, Moscona A. Inhibition of parainfluenza virus type 3 and newcastle disease virus hemagglutinin-neuraminidase receptor binding: Effect of receptor avidity and steric hindrance at the inhibitor binding sites Journal of Virology. 78: 13911-13919. PMID 15564499 DOI: 10.1128/Jvi.78.24.13911-13919.2004  0.726
2004 Moscona A. Oseltamivir-resistant influenza? Lancet. 364: 733-734. PMID 15337382 DOI: 10.1016/S0140-6736(04)16947-X  0.392
2003 Porotto M, Murrell M, Greengard O, Moscona A. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: An HN mutation diminishes the rate of F activation and fusion Journal of Virology. 77: 3647-3654. PMID 12610140 DOI: 10.1128/Jvi.77.6.3647-3654.2003  0.72
2003 Murrell M, Porotto M, Weber T, Greengard O, Moscona A. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir) Journal of Virology. 77: 309-317. PMID 12477836 DOI: 10.1128/Jvi.77.1.309-317.2003  0.746
2001 Prince GA, Ottolini MG, Moscona A. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo Journal of Virology. 75: 12446-12451. PMID 11711635 DOI: 10.1128/Jvi.75.24.12446-12451.2001  0.551
2001 Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: A preliminary experience Journal of Pediatric Gastroenterology and Nutrition. 33: 445-449. PMID 11698761 DOI: 10.1097/00005176-200110000-00005  0.312
2001 Porotto M, Greengard O, Poltoratskaia N, Horga MA, Moscona A. Human parainfluenza virus type 3 HN-receptor interaction: Effect of 4-guanidino-neu5Ac2en on a neuraminidase-deficient variant Journal of Virology. 75: 7481-7488. PMID 11462020 DOI: 10.1128/Jvi.75.16.7481-7488.2001  0.552
2001 Murrell MT, Porotto M, Greengard O, Poltoratskaia N, Moscona A. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity Journal of Virology. 75: 6310-6320. PMID 11413297 DOI: 10.1128/Jvi.75.14.6310-6320.2001  0.736
2001 Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology. 283: 230-9. PMID 11336548 DOI: 10.1006/Viro.2001.0856  0.364
2000 Horga MA, Luca Gusella G, Greengard O, Poltoratskaia N, Porotto M, Moscona A. Mechanism of interference mediated by human parainfluenza virus type 3 infection Journal of Virology. 74: 11792-11799. PMID 11090179 DOI: 10.1128/Jvi.74.24.11792-11799.2000  0.544
2000 Greengard O, Poltoratskaia N, Leikina E, Zimmerberg J, Moscona A. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. Journal of Virology. 74: 11108-14. PMID 11070006 DOI: 10.1128/Jvi.74.23.11108-11114.2000  0.588
2000 Moscona A. Management of respiratory syncytial virus infections in the immunocompromised child Pediatric Infectious Disease Journal. 19: 253-254. PMID 10749471 DOI: 10.1097/00006454-200003000-00017  0.394
1999 Levin Perlman S, Jordan M, Brossmer R, Greengard O, Moscona A. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3 Virology. 265: 57-65. PMID 10603317 DOI: 10.1006/Viro.1999.0024  0.584
1999 Ah-Tye C, Schwartz S, Huberman K, Carlin E, Moscona A. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3 Microbial Pathogenesis. 27: 329-336. PMID 10545258 DOI: 10.1006/Mpat.1999.0313  0.522
1999 Kogan DL, Burroughs M, Emre S, Fishbein T, Moscona A, Ramson C, Shneider BL. Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients Transplantation. 67: 1068-1070. PMID 10221496 DOI: 10.1097/00007890-199904150-00023  0.31
1997 Moscona A. Interaction of human parainfluenza virus type 3 with the host cell surface Pediatric Infectious Disease Journal. 16: 917-924. PMID 9380464 DOI: 10.1097/00006454-199710000-00003  0.414
1996 Moscona A, Peluso RW. Analysis of human parainfluenza virus 3 receptor binding variants: Evidence for the use of a specific sialic acid-containing receptor Microbial Pathogenesis. 20: 179-184. PMID 8965678 DOI: 10.1006/Mpat.1996.0016  0.559
1996 Carlin E, Huberman K, Ah-Tye C, Schwartz S, Moscona A. COMPARISON OF THE VIRUS-RECEPTOR INTERACTIONS OF HUMAN PARAINFLUENZA VIRUSES TYPES 1, 2 and 3. † 995 Pediatric Research. 39: 168-168. DOI: 10.1203/00006450-199604001-01017  0.499
1995 Huberman K, Peluso RW, Moscona A. Hemagglutinin-neuraminidase of human parainfluenza 3: Role of the neuraminidase in the viral life cycle Virology. 214: 294-300. PMID 8525632 DOI: 10.1006/Viro.1995.9925  0.528
1993 Moscona A, Peluso RW. Relative affinity of the human parainfluenza virus type 3 hemagglutinin- neuraminidase for sialic acid correlates with virus-induced fusion activity Journal of Virology. 67: 6463-6468. PMID 8411349 DOI: 10.1128/Jvi.67.11.6463-6468.1993  0.595
1993 Moscona A, Peluso RW. Persistent infection with human parainfluenza virus 3 in CV-1 cells: Analysis of the role of defective interfering particles Virology. 194: 399-402. PMID 8386885 DOI: 10.1006/Viro.1993.1275  0.336
1992 Moscona A, Peluso RW. Fusion properties of cells infected with human parainfluenza virus type 3: Receptor requirements for viral spread and virus-mediated membrane fusion Journal of Virology. 66: 6280-6287. PMID 1328668 DOI: 10.1128/Jvi.66.11.6280-6287.1992  0.489
1991 Moscona A, Peluso RW. Fusion properties of cells persistently infected with human parainfluenza virus type 3: Participation of hemagglutinin-neuraminidase in membrane fusion Journal of Virology. 65: 2773-2777. PMID 1851852 DOI: 10.1128/Jvi.65.6.2773-2777.1991  0.475
1991 Moscona A. Defective interfering particles of human parainfluenza virus type 3 are associated with persistent infection in cell culture Virology. 183: 821-824. PMID 1649512 DOI: 10.1016/0042-6822(91)91018-C  0.391
1991 Moscona A, Peluso RW. Properties of human parainfluenza virus type 3 RNA polymerase/replicase activity in vitro: Consensus with other negative-stranded RNA viruses Journal of Virology. 65: 4470-4474. PMID 1649342 DOI: 10.1128/Jvi.65.8.4470-4474.1991  0.327
1990 Moscona A, Galinski MS. Characterization of human parainfluenza virus type 3 persistent infection in cell culture Journal of Virology. 64: 3212-3218. PMID 2161938 DOI: 10.1128/Jvi.64.7.3212-3218.1990  0.374
1986 Parvin JD, Moscona A, Pan WT, Leider JM, Palese P. Measurement of the mutation rates of animal viruses: Influenza A virus and poliovirus type 1 Journal of Virology. 59: 377-383. PMID 3016304 DOI: 10.1128/Jvi.59.2.377-383.1986  0.466
Show low-probability matches.